Pfizer, Inc.

PFE · NYSE

Pfizer reported FY2025 revenue of $62.6 billion and Q1 2026 revenue of $14.5 billion. The thesis depends on portfolio durability, oncology integration, patent cliffs, operating cash flow, debt capacity and pipeline execution.

Follow Add to Watchlist Ask Question

NYSE PFE Coverage Bootstrap Pharmaceuticals Healthcare Pfizer, Inc.

Latest ReportMay 20, 2026Pfizer: the post-COVID reset still has to prove durable earnings powerView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->

Company filters1 of 1 reports match

Clear filters

Add tags

Selected tags

Healthcare

Clear tags

Latest Thesis

Pfizer: the post-COVID reset still has to prove durable earnings power

May 20, 2026Research reportSlides available

Read report Open slides Discussion (0)

Pfizer, Inc.the post-COVID reset still has to prove durable earnings powerMay 20, 2026

Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.

Recent Reports

Compact report index for this company.

View all 1 reports ->